skin cancer

News

MSD, Moderna skin cancer vaccine scores historic phase 3 win

Strong phase 3 results for Moderna's individualised skin cancer vaccine could pave the way for a leap forward in the field.

News

Regeneron's Libtayo stakes out new territory in skin cancer

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for cutaneous squamous cell carcinoma.

Oncology

Interview at BIO 2025 with Dr Raza Bokhari

Taking chemotherapy directly to skin lesions, with Dr Raza B...

At BIO 2025 in Boston, editor-in-chief Jonah Comstock spoke with Dr Raza Bokhari, CEO of Medicus Pharma.

News

ASCO 25: Regeneron hails Libtayo's adjuvant data in CSCC

Regeneron's PD-1 inhibitor Libtayo hits the mark where MSD's Keytruda missed in a form of non-melanoma skin cancer.

News

a person's arm with skin lesion triaging tool against the skin

Skin Analytics' dermatology AI backed for NHS use

An AI-powered tool for triaging patients with suspicious skin lesions, developed by Skin Analytics, will be used by the NHS to reduce waiting times.

News

Sun Pharma buys Checkpoint and its new cancer drug

Sun Pharma has agreed to acquire Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running short on cash.

MSD, Moderna skin cancer vaccine scores historic phase 3 win

Regeneron's Libtayo stakes out new territory in skin cancer

Taking chemotherapy directly to skin lesions, with Dr Raza B...

ASCO 25: Regeneron hails Libtayo's adjuvant data in CSCC

Skin Analytics' dermatology AI backed for NHS use

Sun Pharma buys Checkpoint and its new cancer drug

Patients not just at the table, but creating their own: In c...

Securing your ROI: Turning post-acquisition integration into...

skin cancer

Editor's Picks